Satsuma Pharmaceuticals Overview

Satsuma Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for STSA.

Quarterly SG&A Expenses

$3.31M

↓ 17.07% YoY

As of Mar 31, 2023

Annual SG&A Expenses (TTM)

$14.45M

↑ 1.53% YoY

Trailing 12 months ending Mar 31, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin